The introduction of nicotinamide as a nicotine substitute in e-cigarette and smokeless items signifies a major regulatory obstacle for your FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to work as a sedative at high dosages6. The statements created by Nicotine River, ECBlend, as well as other vendors that their